全部| 求助中| 待确认 按时间排序|按积分排序

Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study

用户slK1Kxicm8Dw 2天前 10 已完结

Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitors

用户NybQ738PJkRU 2天前 10 待确认

Knowledge, Attitudes, and Practices Regarding Meningococcal B Vaccination Since the 2015 Recommendation: A Review

用户FK38sjWCOeak 2天前 10 已完结

Targeting both wild-type EGFR and its drug-resistant mutants with erlotinib-aptamer conjugates

用户6X7Ch8WUQ_gI 2天前 10 已完结

Discovery and optimization of novel tetrahydrothiazolopyridine-based pyrimidines as highly potent cyclin-dependent kinase 9 (CDK9) inhibitors

用户6X7Ch8WUQ_gI 2天前 10 已完结

Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitors

用户6X7Ch8WUQ_gI 2天前 10 已完结

Rational Design of CZL-S092: A Novel Indazole-Based PLK4 Inhibitor Targeting Neuroblastoma through Virtual Screening and Fragment-Based Drug Design Strategies

用户6X7Ch8WUQ_gI 2天前 10 已完结

Solvation entropy engineering of thermogalvanic electrolytes for efficient electrochemical refrigeration

用户QQ17YeAGVK5g 2天前 10 待确认

Efficacy and safety of transient receptor potential channel modulators for dry eye: A systematic review and meta-analysis

用户6X7Ch8WUQ_gI 3天前 10 已完结

Carbonic anhydrase inhibitors: Structural insights and therapeutic potential

用户hWPe88AByUx0 3天前 10 待确认
首页 上页 8 9 10 11 12 13 14 下页

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com